Report Asia - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Latest Report Update: Sep 15, 2022

Asia - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
Update: COVID-19 Impact

Pricing Plan

You will receive a PDF copy of the report by email within 24 hours (Mon - Fri).

By clicking «Buy the Report», you agree to our Terms of Service, Privacy Policy and Licenses. We'll occasionally send you account related emails.

Asia: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2022

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Asia

The Asian prophylactic medicaments containing insulin market reached $X in 2021, approximately reflecting the previous year. Over the period under review, consumption, however, posted a strong increase. The level of consumption peaked at $X in 2019; however, from 2020 to 2021, consumption remained at a lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Asia

In value terms, prophylactic medicaments containing insulin production totaled $X in 2021 estimated in export price. Overall, production, however, continues to indicate a buoyant increase. The growth pace was the most rapid in 2013 when the production volume increased by X% against the previous year. The level of production peaked at $X in 2019; however, from 2020 to 2021, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Asia

In 2021, prophylactic medicaments containing insulin exports in Asia skyrocketed to X tons, picking up by X% against the previous year. Overall, exports showed significant growth. The most prominent rate of growth was recorded in 2015 with an increase of X% against the previous year. The volume of export peaked in 2021 and is likely to see steady growth in years to come.

In value terms, prophylactic medicaments containing insulin exports surged to $X in 2021. Over the period under review, exports posted a significant increase. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

Exports by Country

India (X tons) and China (X tons) prevails in exports structure, together creating X% of total exports. It was distantly followed by Malaysia (X tons), making up a X% share of total exports.

From 2012 to 2021, the biggest increases were in China (with a CAGR of +X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, China ($X) remains the largest prophylactic medicaments containing insulin supplier in Asia, comprising X% of total exports. The second position in the ranking was held by India ($X), with a X% share of total exports.

In China, prophylactic medicaments containing insulin exports increased at an average annual rate of +X% over the period from 2012-2021. The remaining exporting countries recorded the following average annual rates of exports growth: India (+X% per year) and Malaysia (+X% per year).

Export Prices by Country

In 2021, the export price in Asia amounted to $X per ton, picking up by X% against the previous year. Over the period under review, the export price recorded a resilient expansion. As a result, the export price attained the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was China ($X per ton), while India ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (+X%), while the other leaders experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Asia

In 2021, purchases abroad of medicaments containing insulin but not antibiotics in measured doses increased by X% to X tons, rising for the fourth consecutive year after two years of decline. Total imports indicated a prominent increase from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2017 indices. The pace of growth appeared the most rapid in 2013 when imports increased by X% against the previous year. Over the period under review, imports attained the maximum in 2021 and are likely to see steady growth in years to come.

In value terms, prophylactic medicaments containing insulin imports totaled $X in 2021. Total imports indicated a buoyant expansion from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2017 indices. The pace of growth was the most pronounced in 2013 with an increase of X%. Over the period under review, imports attained the peak figure in 2021 and are expected to retain growth in the immediate term.

Imports by Country

India (X tons) and Turkey (X tons) represented roughly X% of total imports in 2021. It was distantly followed by China (X tons), Japan (X tons), Pakistan (X tons) and Saudi Arabia (X tons), together creating a X% share of total imports. The following importers - South Korea (X tons), Iran (X tons), Indonesia (X tons) and the Philippines (X tons) - together made up X% of total imports.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the leading importing countries, was attained by India (with a CAGR of +X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, China ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in Asia, comprising X% of total imports. The second position in the ranking was held by Japan ($X), with a X% share of total imports. It was followed by Saudi Arabia, with an X% share.

From 2012 to 2021, the average annual growth rate of value in China totaled +X%. The remaining importing countries recorded the following average annual rates of imports growth: Japan (+X% per year) and Saudi Arabia (+X% per year).

Import Prices by Country

The import price in Asia stood at $X per ton in 2021, waning by -X% against the previous year. Overall, the import price saw a pronounced slump. The growth pace was the most rapid in 2019 when the import price increased by X% against the previous year. The level of import peaked at $X per ton in 2012; however, from 2013 to 2021, import prices remained at a lower figure.

Prices varied noticeably countrydestination: the country with the highest price was China ($X per ton), while India ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Pakistan (+X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Base Year Historical Period Forecast Period Units
2021 2007-2021 2022-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in measured doses in Asia?
+
China constituted the country with the largest volume of prophylactic medicaments containing insulin consumption, comprising approx. 66% of total volume. Moreover, prophylactic medicaments containing insulin consumption in China exceeded the figures recorded by the second-largest consumer, India, twofold.
What are the largest producers of medicaments containing insulin but not antibiotics in measured doses in Asia?
+
China constituted the country with the largest volume of prophylactic medicaments containing insulin production, accounting for 66% of total volume. Moreover, prophylactic medicaments containing insulin production in China exceeded the figures recorded by the second-largest producer, India, twofold.
What are the leading exporters of medicaments containing insulin but not antibiotics in measured doses in Asia?
+
In value terms, China remains the largest prophylactic medicaments containing insulin supplier in Asia, comprising 86% of total exports. The second position in the ranking was held by India, with a 7% share of total exports.
What are the leading importers of medicaments containing insulin but not antibiotics in measured doses in Asia?
+
In value terms, China constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in Asia, comprising 33% of total imports. The second position in the ranking was taken by Japan, with a 15% share of total imports. It was followed by Saudi Arabia, with an 8.4% share.
What is the average export price for medicaments containing insulin but not antibiotics in measured doses in Asia?
+
The export price in Asia stood at $277,656 per ton in 2021, rising by 97% against the previous year.
What is the average import price for medicaments containing insulin but not antibiotics in measured doses in Asia?
+
The import price in Asia stood at $193,806 per ton in 2021, waning by -15.4% against the previous year.

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Asia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale
Country coverage:
• Afghanistan
• Armenia
• Bahrain
• Bhutan
• Brunei Darussalam
• Cambodia
• Cyprus
• Democratic People's Republic of Korea
• Georgia
• Jordan
• Kyrgyzstan
• Lao People's Democratic Republic
• Lebanon
• Macao SAR
• Maldives
• Mongolia
• Nepal
• Palestine
• Syrian Arab Republic
• Taiwan (Chinese)
• Tajikistan
• Timor-Leste
• Turkmenistan
• Yemen

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Production in Asia, split by region and country
• Trade (exports and imports) in Asia
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
CONSUMPTION BY COUNTRY
3.3
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCTS

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
7.2
PRODUCTION BY COUNTRY
8. IMPORTS

The Largest Importers on The Market and How They Succeed

8.1
IMPORTS FROM 2012–2021
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Exporters on The Market and How They Succeed

9.1
EXPORTS FROM 2012–2021
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

11. COUNTRY PROFILES

The Largest Markets And Their Profiles

• Afghanistan
• Armenia
• Azerbaijan
• Bahrain
• Bangladesh
• Bhutan
• Brunei Darussalam
• Cambodia
• China
• Hong Kong SAR
• Macao SAR
• Cyprus
• Georgia
• India
• Indonesia
• Iran
• Iraq
• Israel
• Japan
• Jordan
• Kazakhstan
• Kuwait
• Kyrgyzstan
• Lebanon
• Malaysia
• Maldives
• Mongolia
• Myanmar
• Nepal
• Oman
• Pakistan
• Palestine
• Philippines
• Qatar
• Saudi Arabia
• Singapore
• South Korea
• Sri Lanka
• Syrian Arab Republic
• Taiwan (Chinese)
• Tajikistan
• Thailand
• Timor-Leste
• Turkey
• Turkmenistan
• United Arab Emirates
• Uzbekistan
• Vietnam
• Yemen
• Lao People's Democratic Republic
• Democratic People's Republic of Korea
LIST OF TABLES
Table 1:
Key Findings In 2021
Table 2:
Market Volume, In Physical Terms, 2012–2021
Table 3:
Market Value, 2012–2021
Table 4:
Per Capita Consumption, By Country, 2015–2021
Table 5:
Production, In Physical Terms, By Country, 2012–2021
Table 6:
Imports, In Physical Terms, By Country, 2012–2021
Table 7:
Imports, In Value Terms, By Country, 2012–2021
Table 8:
Import Prices, By Country Of Destination, 2012–2021
Table 9:
Exports, In Physical Terms, By Country, 2012–2021
Table 10:
Exports, In Value Terms, By Country, 2012–2021
Table 11:
Export Prices, By Country Of Origin, 2012–2021
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2021
Figure 2:
Market Value, 2012–2021
Figure 3:
Consumption, By Country, 2021
Figure 4:
Market Forecast To 2030
Figure 5:
Products: Market Size And Growth, By Type
Figure 6:
Products: Average Per Capita Consumption, By Type
Figure 7:
Products: Exports And Growth, By Type
Figure 8:
Products: Export Prices And Growth, By Type
Figure 9:
Production Volume And Growth
Figure 10:
Exports And Growth
Figure 11:
Export Prices And Growth
Figure 12:
Market Size And Growth
Figure 13:
Per Capita Consumption
Figure 14:
Imports And Growth
Figure 15:
Import Prices
Figure 16:
Production, In Physical Terms, 2012–2021
Figure 17:
Production, In Value Terms, 2012–2021
Figure 18:
Production, By Country, 2021
Figure 19:
Production, In Physical Terms, By Country, 2012–2021
Figure 20:
Imports, In Physical Terms, 2012–2021
Figure 21:
Imports, In Value Terms, 2012–2021
Figure 22:
Imports, In Physical Terms, By Country, 2021
Figure 23:
Imports, In Physical Terms, By Country, 2012–2021
Figure 24:
Imports, In Value Terms, By Country, 2012–2021
Figure 25:
Import Prices, By Country, 2012–2021
Figure 26:
Exports, In Physical Terms, 2012–2021
Figure 27:
Exports, In Value Terms, 2012–2021
Figure 28:
Exports, In Physical Terms, By Country, 2021
Figure 29:
Exports, In Physical Terms, By Country, 2012–2021
Figure 30:
Exports, In Value Terms, By Country, 2012–2021
Figure 31:
Export Prices, 2012–2021
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET